Predicting outcomes for patients with pulmonary embolism using imaging and clinical data
Population-level Pulmonary Embolism Outcome Prediction with Imaging and Clinical Data: A Multi-Center Study
This study is looking at ways to better treat pulmonary embolism (PE) by using computer technology to combine medical records and CT scan images, helping doctors identify patients who might be at higher risk and tailor their treatment for better outcomes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10914037 on NIH RePORTER |
What this research studies
This research focuses on improving the treatment of pulmonary embolism (PE), a serious condition that can lead to death. By analyzing both clinical data from electronic medical records and imaging data from CT scans, the study aims to develop a method that can predict which patients are at high risk of poor outcomes. The approach utilizes advanced computer algorithms to combine these data sources, allowing for more accurate risk stratification at the point of care. This could lead to more personalized treatment plans and better management of PE cases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pulmonary embolism who require risk assessment for treatment.
Not a fit: Patients with pulmonary embolism who are not receiving treatment or those with very mild cases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance patient safety and healthcare quality by providing tailored treatment strategies for those at high risk of complications from pulmonary embolism.
How similar studies have performed: Other research has shown promise in using similar data-driven approaches for predicting patient outcomes, indicating that this methodology could be effective.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Langlotz, Curtis P — Stanford University
- Study coordinator: Langlotz, Curtis P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.